NRx Pharmaceuticals Inc.
NRXP | NASDAQ
$3.27
-$0.02 (-0.61%)
Sep 22, 2026, 11:01 AM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash & Equivalents | 26.69M | 6.71M | 7.8M | 7.18M | 2.91M | 5.55M | 1.44M | 1.65M | 1.9M | 1.32M | 4.6M | 8.9M | 14.97M | 16.51M | 20.05M | 18.25M | 24.55M | 40.2M | 27.61M | 38.88M | 13.39M | 232 |
Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | 402K | 399K | 397K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 5.97M |
Other Long-Term Assets | 224K | 535K | 253K | 243K | 248K | 334K | 349K | 356K | 384K | 441K | 431K | 21K | 21K | 24K | 21K | 23K | 19K | 17K | 15K | 15.92K | 12.73K | n/a |
Receivables | 206K | 181K | 161K | 3.33M | n/a | n/a | n/a | 6K | 6K | 6K | 6K | 6K | 6K | 6K | 7K | 547K | 554K | n/a | n/a | n/a | n/a | n/a |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -7K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | n/a | n/a | n/a | 400K | n/a | n/a | n/a | n/a | n/a | 128K | n/a | n/a | n/a | n/a | 5.73M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Current Assets | 29.16M | 7.36M | 8.89M | 11.95M | 4.59M | 7.26M | 3.3M | 4.11M | 4.88M | 3.35M | 6.88M | 13.09M | 19.79M | 21.76M | 25.8M | 24.8M | 32.41M | 43.58M | 32.71M | 45.23M | 18.53M | 59.72K |
Property-Plant & Equipment | 1.75M | 936K | 696K | 419K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Goodwill & Intangibles | 2.63M | 2.67M | 2.72M | 2.39M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 5M | 4.54M | 4.06M | 3.05M | 248K | 334K | 349K | 356K | 384K | 441K | 431K | 21K | 21K | 24K | 21K | 23K | 19K | 17K | 15K | 15.92K | 12.73K | 5.97M |
Total Assets | 34.16M | 11.9M | 12.96M | 15M | 4.84M | 7.59M | 3.65M | 4.46M | 5.26M | 3.79M | 7.32M | 13.11M | 19.81M | 21.78M | 25.82M | 24.82M | 32.43M | 43.6M | 32.73M | 45.25M | 18.55M | 6.03M |
Account Payables | 3.15M | 4.4M | 4.27M | 4.26M | 3.63M | 4.31M | 4.13M | 4.87M | 5.02M | 6.27M | 4.63M | 3.63M | 2.21M | 3.78M | 2.08M | 2.17M | 3.08M | 4.31M | 3.69M | 5.56M | 6.27M | 4.38K |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Short-Term Debt | 378K | n/a | 316K | 10.06M | 10.23M | 8.4M | 1.57M | 3.68M | 8.59M | 6.78M | 9.16M | 10.07M | 12.69M | 12.19M | 7.7M | n/a | n/a | 520K | 518K | 515.06K | 173.69K | n/a |
Other Current Liabilities | 30.35M | 14.8M | 23.5M | 21M | 21.42M | 15.12M | 10.93M | 11.35M | 9.6M | 26K | 4.42M | 10K | 36K | 25K | 5.81M | 56K | 19K | 2.61M | 4.87M | 27.06M | 26.39M | 643.69K |
Total Current Liabilities | 33.87M | 25.18M | 28.58M | 40.59M | 40.45M | 32.75M | 21.86M | 20.3M | 23.66M | 18.86M | 19.05M | 19.33M | 22.62M | 22.06M | 15.59M | 8.04M | 7.08M | 11.91M | 11.92M | 36.28M | 35.47M | 643.69K |
Long-Term Debt | 456K | n/a | n/a | n/a | n/a | n/a | 5.01M | 2.99M | n/a | n/a | n/a | n/a | n/a | n/a | 2.82M | n/a | n/a | n/a | n/a | n/a | 512.47K | 2.85M |
Other Long-Term Liabilities | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.31M |
Total Long-Term Liabilities | 456K | 543K | 315K | 158K | n/a | n/a | 5.01M | 2.99M | n/a | n/a | n/a | n/a | n/a | n/a | 2.82M | n/a | n/a | n/a | n/a | n/a | 512.47K | 4.16M |
Total Liabilities | 34.33M | 25.72M | 28.89M | 40.75M | 40.45M | 32.75M | 26.87M | 23.28M | 23.66M | 18.86M | 19.05M | 19.33M | 22.62M | 22.06M | 18.41M | 8.04M | 7.08M | 11.91M | 11.92M | 36.28M | 35.98M | 4.81M |
Total Debt | 834K | 934K | 631K | 10.41M | 10.23M | 8.4M | 6.58M | 6.67M | 8.59M | 6.78M | 9.16M | 10.07M | 12.69M | 12.19M | 10.53M | n/a | n/a | 520K | 518K | 515.06K | 686.17K | 2.85M |
Book Value | -170K | -13.82M | -15.94M | -25.76M | -35.62M | -25.16M | -23.22M | -18.82M | -18.39M | -15.07M | -11.73M | -6.22M | -2.81M | -284K | 7.41M | 16.78M | 25.35M | 31.69M | 20.81M | 8.97M | -17.44M | 1.22M |
Book Value Per Share | 0 | -0.43 | -0.50 | -1.16 | -1.99 | -1.53 | -2.21 | -1.72 | -1.75 | -1.70 | -0.14 | -0.76 | -0.04 | 0 | 0.11 | 0.25 | 0.39 | 0.50 | 0.40 | 0.16 | -0.41 | 0.03 |
Common Stock | 43K | 33K | 32K | 28K | 19K | 17K | 15K | 11K | 11K | 10K | 84K | 84K | 80K | 70K | 67K | 68K | 67K | 67K | 59K | 54.81K | 48.6K | 2.69K |
Retained Earnings | -324.85M | -308.33M | -306.9M | -307.26M | -301.37M | -283.79M | -278.27M | -269.2M | -267.57M | -259.68M | -253.15M | -248.82M | -242.75M | -234.04M | -223M | -212.76M | -203.67M | -196.69M | -183.24M | -152.45M | -131.68M | -1.61M |
Comprehensive Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -3K | -3K | -3K | -22K | -22K | 106K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shareholders Equity | -170K | -13.82M | -15.94M | -25.76M | -35.62M | -25.16M | -23.22M | -18.82M | -18.39M | -15.07M | -11.73M | -6.22M | -2.81M | -284K | 7.41M | 16.78M | 25.35M | 31.69M | 20.81M | 8.97M | -17.44M | 1.22M |
Total Investments | 402K | 399K | 397K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 5.97M |
Add to Watchlist
Select watchlists to add or remove NRXP